title: The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?
abstract: Ulcerative colitis and Crohn's disease together are known as inflammatory bowel disease (IBD). Surgery is considered for more severe disease and is a dreaded consequence for patients. Thiopurines have proven efficacy in the induction and maintenance of remission of IBD, but the long-term need for surgery remains uncertain with conflicting results from the available studies. The timing and duration of thiopurines also appears to play a pivotal role in the management of these conditions and may also affect the need for surgery. Data from Denmark, Canada, Hungary and the UK appear to suggest a reduction in surgery rates prior to the introduction of anti-tumor necrosis factor (TNF) therapy. The authors aim to review the more recent literature evaluating the surgery rates in IBD and changes in disease trends over time. We ask whether increasing thiopurine prescribing has had an effect on the surgery rates in the era of biologic therapy and whether more aggressive treatment approaches have altered the natural history of IBD.
authors.affiliation: Department of Gastroenterology, St George's Hospital University NHS Trust Blackshaw Road, London SW17 0QT.
authors.forename: Vivek
authors.initials: V
authors.lastname: Chhaya
authors.forename: Richard
authors.initials: R
authors.lastname: Pollok